Greystone Associates                                                                                                           The Power of Insight   
Home About Greystone News Events Contact
 Wound Care: Autologous Tissue Repair

Buy This Research

$2,850

 ¤ Buy Now

  Resources   Report
 Autologous Tissue Repair
 

The ability to isolate, purify and re-inject patient-derived cells with regenerative properties has led to a number of therapeutic products for the treatment of refractory injuries and wounds. Autologous tissue repair is having an impact on a number of areas, including cardiovascular medicine, refractory wound care, orthopedics, and surgical medicine. The potential economic benefits of autologous tissue repair are significant, as an aging population struggles with intractable ailments that historically have required numerous follow-up provider visits. While several autologous therapies require remote processing, the number of therapeutic autologous products that can be processed at the point-of-care is increasing. This report details the autologous tissue repair products and development programs of twenty-seven separate companies in seven countries - companies working to shape the future of tissue regeneration.

Publication Date: December 2009

 

Table of Contents

 

Executive Summary

 

Autologous Tissue Repair – Market Structure

Tissue Repair Market Segments

Demographics and Growth

Competitive Landscape

Demand Drivers

Risk Factors

 

Therapeutic Application Segment Analysis

CNS

Orthopedic

   Bone Graft Fixation

   Ligament Repair

Surgical

   Cardiovascular Procedures

   Neurosurgical Procedures

   Plastic/Cosmetic Surgery

Wound Care

   Acute Trauma

   Burns

   Diabetic Ulcers

   Pressure Ulcers

   Venous Ulcers

 

Autologous Therapeutics - Product Analysis, Outlook and Forecasts

 

   Chondrocyte Harvesting

   Cardiovascular Grafts

   Epidermal Grafts

   Macrophage Activation

   Skin Cell Suspension

   Thrombin/Platelet Gels

   Platelet Rich Plasma

   Stem Cell Isolation

     

Market Factors

   Clinical Trial Enrollment

   FDA Guidelines

   Reimbursement

   Evolving Patient Demographics

   Point-of-Care Processing

   Protocols and End-Points

 

Autologous Tissue Repair Company Profiles

 
About Our Reports

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.